Priavoid
Germany - Düsseldorf
BiotechnologyFocus: All-d-peptides
Priavoid envisions to develop disease modifying treatments using a novel compound class combined with a truly unique mode of action.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Phase 2
Clinical Trials (1)
NCT06182085Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2022
Portfolio: 1 clinical trial
Publications: 8 in PubMed